These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 25865931)

  • 21. Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming.
    Price ML; Kirby LG; Valentino RJ; Lucki I
    Psychopharmacology (Berl); 2002 Aug; 162(4):406-14. PubMed ID: 12172694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructural evidence for a role of gamma-aminobutyric acid in mediating the effects of corticotropin-releasing factor on the rat dorsal raphe serotonin system.
    Waselus M; Valentino RJ; Van Bockstaele EJ
    J Comp Neurol; 2005 Feb; 482(2):155-65. PubMed ID: 15611993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
    Staub DR; Evans AK; Lowry CA
    Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatosensory regulation of serotonin release in the central nucleus of the amygdala is mediated via corticotropin releasing factor and gamma-aminobutyric acid in the dorsal raphe nucleus.
    Tokunaga R; Shimoju R; Shibata H; Kurosawa M
    J Physiol Sci; 2017 Nov; 67(6):689-698. PubMed ID: 27744641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity.
    Forster GL; Pringle RB; Mouw NJ; Vuong SM; Watt MJ; Burke AR; Lowry CA; Summers CH; Renner KJ
    Eur J Neurosci; 2008 Jul; 28(2):299-310. PubMed ID: 18702701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram.
    Zohar I; Dosoretz-Abittan L; Shoham S; Weinstock M
    Psychopharmacology (Berl); 2015 May; 232(9):1643-53. PubMed ID: 25420605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-34 Contributes to the Stress-related Behavior and Affects 5-HT Prefrontal/GABA Amygdalar System through Regulation of Corticotropin-releasing Factor Receptor 1.
    Andolina D; Di Segni M; Accoto A; Lo Iacono L; Borreca A; Ielpo D; Berretta N; Perlas E; Puglisi-Allegra S; Ventura R
    Mol Neurobiol; 2018 Sep; 55(9):7401-7412. PubMed ID: 29417477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress.
    Henry B; Vale W; Markou A
    J Neurosci; 2006 Sep; 26(36):9142-52. PubMed ID: 16957071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.
    Kirby LG; Rice KC; Valentino RJ
    Neuropsychopharmacology; 2000 Feb; 22(2):148-62. PubMed ID: 10649828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction.
    Valentino RJ; Lucki I; Van Bockstaele E
    Brain Res; 2010 Feb; 1314():29-37. PubMed ID: 19800322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
    Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
    J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility.
    Snyder K; Wang WW; Han R; McFadden K; Valentino RJ
    Neuropsychopharmacology; 2012 Jan; 37(2):520-30. PubMed ID: 21993205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats.
    Zhao Y; Valdez GR; Fekete EM; Rivier JE; Vale WW; Rice KC; Weiss F; Zorrilla EP
    J Pharmacol Exp Ther; 2007 Dec; 323(3):846-54. PubMed ID: 17855476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress.
    Hammack SE; Pepin JL; DesMarteau JS; Watkins LR; Maier SF
    Behav Brain Res; 2003 Dec; 147(1-2):55-64. PubMed ID: 14659570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticotropin-releasing factor in ventromedial prefrontal cortex mediates avoidance of a traumatic stress-paired context.
    Schreiber AL; Lu YL; Baynes BB; Richardson HN; Gilpin NW
    Neuropharmacology; 2017 Feb; 113(Pt A):323-330. PubMed ID: 27235163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress-hyperresponsive WKY rats demonstrate depressed dorsal raphe neuronal excitability and dysregulated CRF-mediated responses.
    Lemos JC; Zhang G; Walsh T; Kirby LG; Akanwa A; Brooks-Kayal A; Beck SG
    Neuropsychopharmacology; 2011 Mar; 36(4):721-34. PubMed ID: 21160465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
    Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
    J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of alcohol-heightened aggression by CRF-R1 antagonists in mice: critical role for DRN-PFC serotonin pathway.
    Quadros IM; Hwa LS; Shimamoto A; Carlson J; DeBold JF; Miczek KA
    Neuropsychopharmacology; 2014 Nov; 39(12):2874-83. PubMed ID: 24917195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRF modulates glutamate transmission in the central amygdala of naïve and ethanol-dependent rats.
    Varodayan FP; Correia D; Kirson D; Khom S; Oleata CS; Luu G; Schweitzer P; Roberto M
    Neuropharmacology; 2017 Oct; 125():418-428. PubMed ID: 28807676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.